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Purpose: This study sought to further validate the efficacy of the SPOTTM 
photoscreener version (v) 3.0.0500 as a screening device for amblyopia risk factors 
(ARF). 
 
Methods: This was a cross-sectional study from five different western South Dakota 
outpatient clinics. Data from 610 eyes of 305 children aged 6 months to 13.5 years 
collected between July 2018 to September 2018 were analyzed, using both the out-
of-box referral criteria and the 2013 American Association for Pediatric 
Ophthalmology and Strabismus (AAPOS) referral criteria. Optometrist (eye care 
provider or ECP) cycloplegia practice patterns were deferred to each clinics’ 
specific protocols. Power vector and Bland-Altman plot analyses were performed. 
 
Results: The average age of the 305 children in the study population is 99.6 months 
(~8.3 years), with a total of 42% of these subjects receiving no dilating drops prior 
to testing. From these cases, the SPOTTM v3.0.0500 photoscreener evaluation 
parameters for detecting ARFs using the out-of-box referral criteria yielded an 
overall sensitivity (SN) of 95.2%, specificity (SP) of 91.9%, positive predictive 
value (PPV) of 81.6%, and negative predictive value (NPV) of 98.1%; the SPOTTM 
v3.0.0500 photoscreener evaluation parameters for detecting ARFs using the 2013 
AAPOS referral criteria yielded an overall SN of 96.3%, SP of 92.4%, PPV of 
82.1%, and NPV of 98.6%.  
 
Conclusions: With SN and NPV values exceeding 95%, this study supports the 
efficacy of the SPOTTM v3.0.0500 photoscreener as a pediatric screening device to 
detect ARFs. Power vector analyses help to provide further objective comparisons 
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Amblyopia is a significant cause of pediatric vision loss but is preventable and 
treatable with early recognition.1-5 Strabismus, anisometropia spherical equivalent, 
and occlusion are all considered risk factors for amblyopia (ARF) in young 
children. Other ARFs include premature birth, maternal substance abuse during 
pregnancy, and family history of amblyopia in a first-degree relative.6 The 
consequences of untreated amblyopia may be permanent and often begin in 
childhood with slower reading,7 decreased fine motor skill functioning,8 and 
adverse emotional ramifications.9,10 If the non-amblyopic eye is injured or affected 
by disease, long-term visual performance consequences include impaired facial 
perception,11 increased risk of bilateral vision impairment,12 as well as total 
blindness.13 As of 2020, eight states, including South Dakota, are without a 
designated pediatric vision screening policy.14 To date, a comprehensive proposal 
has never been brought forward to the South Dakota State Legislature. 
 
Amblyopia Treatment and Screening Efforts 
Standard of amblyopia care entails guiding therapy based upon identified risk 
factors. Efficacious strategies, ideally within the first decade of life, include 
optimizing refractive correction, removing physical occlusions, correcting the 
strabismic eye with surgery, and penalizing the non-amblyopic eye 
(pharmacologically or through occlusive patching).15-18 Without adequate optic 
input during this critical period, the visual cortex fails to develop properly and 
vision is permanently impaired.19 In 2017, the United States Preventive Services 
Task Force published its updated evidence report, recommending vision screening 
for all patients aged 3-5 years old, with growing support for ARF screening under 
the age of 3.20-25 Therefore, early screening and tailored therapy remain atop eye 
care providers’ priorities in the management of amblyopia. 
 
SPOTTM Photoscreening 
Photoscreening is the process of interpreting photos to screen for ocular defects 
associated with amblyopia. Photoscreening devices and vision screening initiatives 
have been extensively studied and continue to be shown to be cost-effective, 
efficient, and effective methods for ARF detection.5 As such, photoscreening 
devices have been endorsed by the American Academy of Pediatrics, the American 
Academy of Ophthalmology, the American Association of Certified Orthoptists, 
the Children’s Eye Foundation, and the American Association for Pediatric 
Ophthalmology and Strabismus (AAPOS).26,27  
 
3
Kudrna et al.: SPOT™ Photoscreener’s Efficacy Detecting Amblyopia Risk Factors
Published by USD RED, 2021
   
 
The current study evaluates the SPOTTM v3.0.0500 photoscreener (Welch Allyn, 
Skaneateles Falls, New York, USA). Several SPOTTM-related studies have looked 
at photoscreener evaluation parameters using different referral criteria, albeit with 
varying study designs and software versions: SPOTTM  v1.0.3 software (SN 89-
92%, SP 41-71%),28 SPOTTM  v1.1.50 software (SN 86%, SP 90%),29 SPOTTM 
v1.1.51 software (SN 80-89%, SP 74-88%, PPV 88%, NPV 61%),28,30-33 SPOTTM 
v2.0.16 software (SN 85-93%, SP 70-91%, PPV 58-82%, NPV 79-99%),22,34,35 
SPOTTM v2.1.4 (SN 84-94%, SP 62-80%, PPV 52-62%, NPV 86-96%),36-38 
SPOTTM v3.0.04.06 (SN 61%, SP 95%, PPV 76%, NPV 90%),39 and SPOTTM 
version not specified (SN 86%, SP 70%, PPV 79%, NPV 79%).40 To the authors’ 
knowledge, photoscreener evaluation parameters in pediatric populations have yet 
to be published using the SPOT TM v3.0.0500 software. 
 
Study Objectives 
The primary objective of this study is to compare the collected screening data from 
the updated SPOTTM v3.0.0500 software with same-day optometrists’ (eye care 
provider or ECP) analyses by constructing 2x2 tables to calculate photoscreener 
evaluation parameters and provide validation of the SPOTTM efficacy. A secondary 
objective is to assess the study population demographics. A tertiary objective is to 
obtain power vector analysis on the data as a point of comparison for future studies. 
Lastly, in conjunction with previous South Dakota SPOTTM publications,3,6,41,42 
state leaders could use this information to support legislation requiring childhood 
vision screenings in states like South Dakota, without such laws in place. 
 
Patients and Methods 
 
Study Design and Data Collection 
This cross-sectional study represents a continuation of efforts in collaboration with 
Northern Plains Eye Foundation (NPEF) and its Children’s Vision Screening 
Initiative (CVSI). The mission of NPEF is to protect and preserve vision and restore 
sight for people of the Northern Plains; this geographical area includes all of South 
Dakota, Northeastern Wyoming, Southeastern Montana, Southwestern North 
Dakota, and Northwestern Nebraska. The primary research mission of NPEF CVSI 
is to assess the efficacy of the SPOTTM photoscreener, which has been supported in 
four publications to date.3,6,41,42 The current study was approved by The University 
of South Dakota Sanford School of Medicine’s Institutional Review Board and 
conformed to the requirements of the United States Health Insurance Portability 
and Accountability Act of 1996. Informed consent was obtained from the parents 
(or guardians) of patients presenting for a routine yearly pediatric eye examination 
from their local optometrist. 
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Patients aged 6 months to 13.5 years who received both the SPOTTM screening and 
comprehensive eye examination on the same day were included in this analysis. 
Voluntary participation in the study came from twelve experienced ECPs, at five 
different eye clinics, in three western South Dakota communities – Rapid City, 
Belle Fourche, and Pierre. Following same-day training from experienced NPEF 
staff, optometric technicians at each eye clinic were responsible for conducting the 
SPOTTM screening prior to the subject’s routine, yearly, comprehensive eye 
examination by the patient’s local optometrist. The ECPs were asked to complete a 
comprehensive eye examination for each subject, in accordance with their clinics’ 
protocol. The ECPs were masked to all SPOTTM screening results. Each clinic 
collected SPOTTM and ECP data from July 2018 to September 2018. NPEF staff 
followed an established process for organizing and digitally uploading the data to 
a secure database. 
 
Device 
Introduced in 2011, the SPOTTM photoscreener (Welch Allyn, Co.) is a user-
friendly, handheld, noninvasive, touchscreen, portable, rechargeable device. Its 
infrared camera captures the patient’s reflected (red) reflex, and in seconds, the user 
can obtain binocular refractive error, pupillary size, and gaze measurements. The 
device is held about three feet from the subject while lights and sounds are emitted 
from the device to attract the patient’s attention. All measurements may be obtained 
on the device without any need for physical contact with the child, verbal input 
from the child, or pupillary dilation/cycloplegia of the child. 
 
The effectiveness of the SPOTTM photoscreener to separate patients into a group 
that requires more extensive ECP evaluation supports its use as a screening tool. 
The subject receives either a “screening complete” (screen negative) or “complete 
eye exam recommended” (screen positive) designation based upon preset cutoff 
values for ARFs. For simplicity, a “screening complete” result will be referred to 
as “pass” and a “complete eye exam recommended” result will be referred to as 
“referral” henceforth. These referral criteria can be manually programmed based 
on desired cutoff values for levels of astigmatism, strabismus, and anisometropia. 
Welch Allyn reports the following accuracy measurements for the refractive error 
measurements of SPOTTM: ±0.25-0.5D for sphere (S), ±0.50-1.00D for cylinder 
(C), and ±5 degrees for cylinder axis (A). The SPOTTM software v3.0.0500 was 
used in this study, and Welch Allyn conducts regular software updates to optimize 
SPOTTM performance. Functional advantages of SPOTTM include the ability to 
change referral criteria based on user’s needs, simultaneous binocular screening, 
direct estimate of refractive error, concomitant detection of media opacities, 
concomitant detection of strabismus, as well as instantaneous results.5,28,30-32,35 The 
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primary functional disadvantages of SPOTTM are overestimation of astigmatism 
and underestimation of moderate to severe hyperopia.5,29,43,44 
 
Data Analysis and Statistics 
First, collective demographic information (age, race, gender) was calculated using 
descriptive statistics. Second, 2x2 tables were constructed, beginning with ARF 
status assignment to help address inter-ECP examination variability. ARF status for 
each subject was determined by comparing the ECP’s S and positive C 
measurements to those listed in the 2018 Pediatric Ophthalmology/Strabismus 
(POS) Preferred Practice Pattern Panel (PPPP) refractive treatment criteria. The 
subject was deemed to have an ARF present if any of the four ARF criteria 
(anisometropia, astigmatism, myopia, and/or hyperopia) exceeded the values listed 
in Table 4C for either eye. Next, the S and positive C obtained from the SPOTTM 
photoscreener were compared to the referral criteria values in Table 4A (adapted 
SPOTTM v3.0.0500 out-of-box) and gold standard, cycloplegic exam cutoff values 
in Table 4B (adapted 2013 AAPOS) to determine true positives (TP), true negatives 
(TN), false positives (FP), and false negatives (FN). Standard calculations for SN, 
SP, PPV, and NPV were subsequently performed. 
 
Finally, in an effort to further objectively compare refractive error data quality 
between SPOTTM photoscreening results and ECP refraction measurements for 
statistical significance, the univariate, clinical measures of S, C, A were 
transformed into power vector notation of spherical equivalent lens of a refraction 
in diopters (M), vertically-oriented Jackson Cross-Cylinder (JCC) at 0 degrees with 
power J0 (J0), and obliquely oriented JCC at 45 degrees with power J45 (J45).
45 The 
clinical (S, C, A) to vector (M, J0, J45) conversion (C2V) was performed in 
Microsoft Excel; this C2V notation input may be performed in either plus cylinder 
notation or minus cylinder notation.46 For this study, power vector analysis was 
carried out with S, C, A values in negative cylinder. For readability purposes, J0 
and J45 values are color coded blue and red, respectively, in all tables and figures 
henceforth. 
 
Once in power vector format, a two-tailed, Student T-test, with a 95% confidence 
interval (CI) was generated for both the left eye (OS) and the right eye (OD), using 
the mean differences from the M, J0, and J45 values as calculated from SPOT
TM and 
ECP’s refractive (S, C, A) measurements. This arithmetic was carried out using the 
following Microsoft Excel functions: “=.CONFIDENCE.T” and “=.STDEV.P”.47 
For each measurement, if the standard deviations of the ECP and SPOTTM differed 
by double (or more) the other, unequal variances were assumed; otherwise, equal 
variances were assumed. The spherical equivalent was calculated for each subject 
using the following formula: [ECP’s S measurement] + [(0.5)*(ECP’s C 
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measurement)]; this calculation is the same in positive or negative cylinder 
astigmatism values. 
Mean, standard deviation (SD), 95% CI, and p-values were rounded to two-
significant figures. For this study, the evaluation parameters SN, SP, PPV, NPV 
were calculated following conversion to plus cylinder.  
 
To further objectively compare SPOTTM and ECP refractive error measurements, 
Bland-Altman analysis was performed on the J0 and J45 power vector data for OD 
and OS. The Bland-Altman plot methods have been described previously.48,49 The 
Bland-Altman scatter plots show average ECP and SPOTTM power vector values 
for each eye plotted against the ECP minus SPOTTM differences for the same eye. 
The mean bias is calculated as the average of the differences plotted on the y-axis 
while the upper and lower limits of agreement (LOA) are calculated and plotted as 
± 1.96 SD from the mean bias also on the y-axis. In this study, bias refers to the 
average discrepancy between the SPOTTM and ECP refractive error measurements.  
Results 
From July 2018 through September 2018, a total of 317 children presented to their 
local optometrists’ outpatient clinics in western South Dakota for routine 
evaluation. Subjects were excluded from data analysis if there was no consent form 
signed, if the SPOTTM result was not obtained, or if there was not clear refractive 
information documented on the ECP’s form. Ultimately, data was analyzed from 
610 eyes of 305 patients (Figure 1). These subjects were evaluated at the following 
five western South Dakota clinics: 70% (N=213 subjects) Drs. Tucker-Kudrna-
Holec-Young Eye Care Centre, 16% (N=48 subjects) Central Dakota Eyecare, 
9.2% (N=28 subjects) Independent Eyes, 3.9% (N=12 subjects) Redwater Eye 
Care, and 1.3% (N=4 subjects) Black Hills Regional Eye Institute. This study 
population consisted of 45% male and 55% female, with an average age of 99.6 
months (~8.3 years), ranging from 6 months to 162 months (~13.5 years), with 78% 
of subjects being over 73 months (~6.1 years) (Table 1). Dilation of the subjects 
was performed according to each clinic’s preferred protocol (Table 2). White (73%) 
and American/Indian/Alaska Native (14%) composed the subjects’ racial 
demographic majority (Table 3). The average age of the 11 subjects – representing 
3.6% of the total population screened – diagnosed with amblyopia was 98 months 
(~8.1 years). The out-of-box SPOTTM v3.0.0500 referral criteria settings, the 2013 
AAPOS referral criteria, and the 2018 POS PPPP guidelines are juxtaposed in Table 
4.  
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Figure 1: Flow chart depicting selection of the 305 subjects analyzed for this study. 
 
 
Table 1: SPOTTM photoscreening population age and gender distributions.  














(73 - 162)  
Gender  Total  
N= 305; 
100%  
2; 0.66%  4; 1.3%  14; 4.6%  47; 15%  238; 78%  
Male  
N=137; 45%  
1  1  4  22  109  
Female  
N=168; 55%  
1  3  10  25  129 
 
Table 2: Summary of methods of dilation used during eye care professional examination.  
Dilating eye drops used  N (%)  
No dilation  128 (42%)  
Tropicamide (Mydriacyl) 1%  106 (35%)  
Cyclopentolate (Cyclogel) 1%  28 (9.2%)  
Tropicamide (Mydriacyl) 1% + Phenylephrine (Neofrin) 2.5%  24 (7.9%)  
Tropicamide (Mydriacyl) 1%  + Norpholedrine (Paremyd) 0.25%  12 (3.9%)  
No information provided  4 (1.3%)  
Cyclopentolate (Cyclogel) 2.5%  3 (0.98%)  
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Table 3: SPOTTM photoscreening population racial demographics. ^17 subjects identified as more 
than 1 ethnicity. +Subject race was not designated on eye care professional evaluation form. %, 
percentage of total study population.  
Race  N (%)  N Diagnosed with 
Amblyopia (%)  
White  223 (73%)  9 (3%)  
American Indian/Alaska Native  43 (14%)  2 (0.7%)  
Unknown+  17 (5.6%)  0  
Other^  17 (5.6%)  0  
Hispanic  3 (0.98%)  0  
Asian  1 (0.33%)  0  
Black/African American  1 (0.33%)  0  
Native Hawaiian/Other Pacific 
Islander  




Table 4: Adapted pediatric refractive referral or treatment criteria. Listed values are the minimum 
for referral or treatment. Anisometropia refers to the difference in spherical equivalent 
measurements between eyes. D, diopters. v, version.  
 
A) Adapted pediatric refractive referral criteria for 
the SPOTTM photoscreener v3.0.0500. The limit of detected myopia and hyperopia is –
7.50 D and 7.50 D, respectively. The fourth age cohort is published as 73-240 months but 
assumed to be > 73 months for our data analysis. v, version.  
 
B)  Adapted 2013 American Association for Pediatric Ophthalmology and Strabismus gold 
standard, cycloplegic exam cutoff criteria. The first age cohort is published as 12-30 
months, but this range is assumed to be < 30 months, for the purposes of the current 
study. All ages manifest strabismus > 8 prism diopters in primary position as well as all 
ages with a media opacity > 1 millimeter should be referred for an eye care professional 
examination.   
 
C)) Adapted 2018 Pediatric Ophthalmology/Strabismus Preferred Practice Pattern Panel 
recommended refractive treatment criteria. Because there are no scientifically rigorous 
published data for guidance, these values 
are based on an expert consensus of professional experiences and clinical 
impressions. The fourth age cohort is published as 36-47 months, but this range 
is assumed to be ≥ 36 months, for the purposes of the current study. Listed anisometropia 
values are without strabismus present. *, if myopia present. **, if hyperopia or astigmatism 
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Table 4A. Adapted SPOTTM photoscreener (v3.0.0500) manufacturer refractive referral criteria.  
Age Range (months)  Anisometropia (D)  Astigmatism (D)  Myopia (D)  Hyperopia (D)  
6-12  1.50  2.25  -2.00  3.50  
12-36  1.00  2.00  -2.00  3.00  
37-72  1.00  1.75  -1.25  2.50  
> 73  1.00  1.50  -1.00  2.50  
  
Table 4B. Adapted 2013 American Association for Pediatric Ophthalmology and 
Strabismus Vision Screening Committee gold standard, cycloplegic exam cutoff criteria.  
Age Range (months)  Anisometropia (D)  Astigmatism (D)  Myopia (D)  Hyperopia (D)  
< 30  2.50  2.00  -3.50  4.50  
31-48  2.00  2.00  -3.00  4.00  
> 48  1.50  1.50  -1.50  3.50  
  
Table 4C. Adapted 2018 Pediatric Ophthalmology/Strabismus 
Preferred Practice Pattern Panel refractive treatment criteria.  
Age Range (months)  Anisometropia (D)  Astigmatism (D)  Myopia (D)  Hyperopia (D)  
< 12  4.00 *  
  2.50 **  
3.00  -5.00  6.00  
       2.00 ***  
12-23  3.00 *  
  2.00 **  
2.50  -4.00  5.00  
        2.00 ***  
24-35  3.00 *  
       2.00 ****  
         1.50 *****  
2.00  -3.00  4.50  
       1.50***  
≥ 36  2.50 *  
   1.50 **  
1.50  -2.50  3.50  
       1.50 ***  
 
 
Our reported SPOTTM v3.0.0500 photoscreener evaluation parameters using the 
out-of-box referral criteria yielded an overall SN of 95.2%, SP of 91.9%, PPV of 
81.6%, and NPV of 98.1%. The SPOTTM v3.0.0500 photoscreener evaluation 
parameters using the 2013 AAPOS referral criteria yielded an overall SN of 96.3%, 
SP of 92.4%, PPV of 82.1%, and NPV of 98.6%. These results are summarized in 
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Table 5: SPOTTM v3.0.0500 photoscreener evaluation parameters using different referral 
criteria. The SPOTTM referral and pass screens varied based on whether the SPOTTM v3.0.0500 
referral criteria or the 2013 AAPOS referral criteria was used as the cutoff criteria for determining 
screen positive and screen negative. The 2018 Pediatric Ophthalmology/Strabismus Preferred 
Practice Pattern Panel consensus opinion treatment criteria was applied to eye care professionals’ 
refractions and used to determine subjects’ amblyopia risk factor (ARF) status. Table 4 delineates 
the cutoff values for each of these criteria. AAPOS, American Association for Pediatric 
Ophthalmology and Strabismus. v, version. SN, sensitivity. SP, specificity. PPV, positive predictive 
value. NPV, negative predictive value.  
  SPOTTM photoscreener   
v3.0.0500:  
out-of-box referral criteria  
SPOTTM photoscreener   
V3.0.0500:  
2013 AAPOS referral criteria  
ARF present  ARF not 
present  
ARF present  ARF not 
present  
SPOTTM referral  
(screen positive)  
80  18  78  17  
SPOTTM pass  
(screen negative)  
4  203  3  207  
Evaluation 
parameters of 
SPOTTM v3.0.0500  
SN = 95.2%  SP = 91.9%  SN = 96.3%  SP = 92.4%  
PPV = 81.6%  NPV = 98.1%  PPV = 82.1%  NPV = 98.6%  
 
The results of power vector comparison analysis between SPOTTM v3.0.0500 and 
ECP examinations provide a novel comparison of power vector data (Table 6).46 
Statistically significant differences were only found between OD J0 and J45 
(p=0.019 and p=3.8E-6, respectively) as well as OS M and J45 (p=0.025 and 
p=7.9E-10, respectively). The magnitude of differences (MOD) was calculated to 
be OD MOD 0.74 and OS MOD 0.80. The vector difference in diopters (VDD) was 
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Table 6: Power vector comparison of refractive error measurements from entire study population. 
MOD, magnitude of differences. VDD, vector difference in diopters. D, diopters. CI, 95% 
confidence interval for the population mean, using a Student’s T-distribution. *, statistically 
significant (p≤0.05).  J0, Jackson Cross-Cylinder lens equivalent at 0°. J45, Jackson Cross-Cylinder 
lens equivalent at 45°. M, spherical equivalent. OD, right eye. OS, left eye. ECP, eye care 
professional (refractive error from cycloplegic evaluation form). SD, standard deviation.  
Eye   Measurement  Mean (in D)  SD (in D)  95% CI  p-value  
OD  
   N=305 eyes of 
305 patients  
M  SPOT  0.13  1.2  0.13  0.061  
ECP  0.33  1.5  0.17  
J0  SPOT  0.43  0.64  0.072  0.019*  
ECP  0.31  0.61  0.068  
J45  SPOT  0.14  0.26  0.029  3.8E-6*  
ECP  0.05  0.24  0.027  
MOD  SPOT  0.74     
ECP  
VDD  SPOT  1.0  
ECP  
OS  
   N= 305 eyes of 
305 patients  
M  SPOT  0.13  1.2  0.14  0.025*  
ECP  0.39  1.6  0.18  
J0  SPOT  0.32  0.59  0.066  0.23  
ECP  0.26  0.59  0.066  
J45  SPOT  0.090  0.25  0.028  7.9E-10*  
ECP  -0.040  0.26  0.030  
MOD  SPOT  0.80     
ECP  




In the Bland-Altman analysis (Figures 2-5), SPOTTM consistently shows mean bias 
of greater astigmatism power vector values, and therefore cylinder values, 
compared to ECP. This leads to negative mean bias, which is consistent throughout 
the range of average measurements between ECP and SPOTTM, meaning there is 
no proportional bias to the measurements.  
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Figures 2-5: Bland-Altman plots comparing OD and OS J0 (blue) and J45 (red) power vector values 
for ECP and SPOTTM refractions. J0, Jackson Cross-Cylinder lens equivalent at 0°. J45, Jackson 
Cross-Cylinder lens equivalent at 45°. OD, right eye. OS, left eye. ECP, eye care professional 
(refractive error from cycloplegic evaluation form). SPOTTM, refractive error from SPOTTM 
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Towards Routine Use of the SPOTTM Photoscreener and Power Vector Analysis 
With SN and NPV exceeding 95%, this study certainly supports the efficacy of the 
SPOTTM v3.0.0500 software as a screening device in western South Dakota. The 
favorable screening parameters obtained in this study provide significant validation 
for use in this geographic area. As with any photoscreening device, there remains a 
need to continually refine criteria parameters; our study, and others like it, help to 
provide guidance to this end. In this process of optimizing photoscreener referral 
parameters/rates appropriate for these pediatric office locations and age of child, 
other objective screening data, namely power vector analyses, may represent a 
promising step in the right direction to help decrease the burden of inappropriate 
referrals and unnecessary expenses.  
 
The power vector values of M, J0, J45, MOD, and VDD provide specific, 
complimentary information to more completely optimize SPOTTM photoscreening 
use. Furthermore, Bland-Altman analysis of J0 and J45 allow for a generalizable 
comparison of ECP and SPOTTM refractive error measurements. Thus, evidence-
based refinement of multiple objective parameters may help to support standardized 
definitions of photoscreener outcome variables and customize photoscreening data 
in a population-specific manner for the purpose of routine photoscreener use. 
 
Assumptions Regarding ECP Recommendations and SPOTTM Photoscreening 
Results 
Developing standardized definitions of SPOTTM photoscreening outcome variables 
require making consistent assumptions. For the current study, these assumptions 
were necessary to ensure valid counts of TP, TN, FP, and FN in the post hoc 
analysis of the ECP recommendations (Table 5). Throughout the study, we were 
mindful of differences in ECPs’ practice patterns as well as the nuances specific to 
unique patient situations. ECPs are known, for many evidence-based reasons, to 
prescribe ARF-preventing interventions at refractive targets below ARF thresholds 
in preferred practice guidelines. Therefore, instead of letting the decision from the 
ECP determine the ARF status columns in Table 5, we applied the 2018 POS PPPP 
findings to the S and C measurements documented by the ECP to decide whether 
an ARF was present or not. For the rows in Table 5, a SPOTTM photoscreening 
“referral” (screen positive) indicates the subject should be referred for ECP 




Kudrna et al.: SPOT™ Photoscreener’s Efficacy Detecting Amblyopia Risk Factors
Published by USD RED, 2021
   
 
Interpreting SPOTTM Photoscreener Results 
Comparing SPOTTM photoscreener evaluation parameters of SN, SP, PPV, and 
NPV values in our study with those reported in previous studies should be 
interpreted with a few considerations in mind. Each photoscreener study is 
performed with nuanced differences in subject population, study designs, 
photoscreener product/software updates, and across diverse clinical environments. 
In the end, as a screening tool, photoscreener use is not intended to “outperform” 
other populations or supplant yearly optometric eye examinations, but rather 
photoscreeners serve as an accessible first step to potentially sight-saving care, 
particularly in underserved populations. 
 
Interpreting Power Vector Analyses 
For this study, the common language of Thibos et al. and the readily performed 
C2V calculations described by Miller were used to interconvert the refractive 
measurements of S, C, and A into power vector notation of M, J0 , J45, 
respectively.45,46 Our study helps to serve as one benchmark comparison for power 
vector values, but additional studies are warranted to establish normal ranges for 
these values as well as the p-values that imply both statistical and clinical 
significance. 
 
Clinical application of power vectors facilitates more standardized descriptions of 
refractive error.45,47,50,51  These power vector calculations allow for a consolidated 
understanding and objective comparison of numerical data from multiple 
refractions, beyond photoscreener brand and ECP practice preferences. Augmented 
understanding and application of power vectors allow for more precise control of 
photoscreener experimental protocols and extraction of more meaning from 
refractive data. As photoscreening continues to increase in use and software updates 
refine screening parameters based on evidence in a patient population-specific 
manner, the need grows for a common language to facilitate clear communication 
across providers and technologies.5 We expect clinical protocols for photoscreening 
devices, as dictated by the published evidence, to integrate use of power vectors 
and its associated terminology. 
 
The power vector analysis of our data differed slightly from the previous western 
South Dakota power vector analysis.6 While the previous study reported p≤0.05 in 
both eyes (OU) M values, our study reports statistical significance with the same p-
value definition in the values of OD J0, OD J45, OS M, and OS J45. When attempting 
to reconcile these findings, it is important to remember a few items. First, the 
current study did not mandate the gold-standard cycloplegic exam. Cycloplegic 
refraction reveals uncorrected refractive status of children by preventing the child’s 
ability to accommodate. For the purposes of this study, we accepted the limitation 
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of not administering cycloplegic drops to every patient in order to increase clinics’ 
participation in the study. Next, the average age of our study population was 99.6 
months compared to the 72 months previously reported.6 What may be statistically 
significant in an older patient population may not be statistically significant in 
another. Likewise, the clinical significance of these statistically significant power 
vector analysis values remains to be determined. Lastly, conducting multiple 
hypothesis tests without proper adjustment to the alpha value (kept at 0.05 for both 
performance parameter and power vector analysis) runs the risk of increasing type 
1 (alpha) error. While p-values are conventionally chosen and generally accepted 
in the scientific community at 0.05, by definition, this number itself is still a value 
that is chosen arbitrarily and may not necessarily be appropriate for power vector 
analysis. Accounting for this multiplicity (multiple testing) problem could be 
addressed by tweaking the alpha value for the performance parameters (SN, SP, 
PPV, NPV) versus the power vector analysis (M, J0 , J45), once the statistical and 
clinical significance interplay is better understood. 
 
In addition to M, J0 , J45, two other power vector values carry clinical significance. 
The MOD, and associated VDD, are currently used to help identify representative 
refractions as a form of median measurement,46 because MOD and VDD can be 
followed over time to lend validity to various refractions. In this way, MOD and 
VDD values can identify the extent of dispersion in a set of observations of different 
refractions from multiple providers/photoscreening devices and have threshold 
values set for MOD and VDD. Thus, as MOD and VDD increase in magnitude, 
confidence is increased that the refractions being compared are objectively 
changing in a meaningful manner. For this study, the similar median values for the 
average MOD OD (0.74D) and OS (0.80D) and similar median values for the 
average VDD OD (1.0D) and OS (1.1D) suggest similar magnitude power vectors 
of the SPOTTM photoscreener and the ECP (Table 6). However, the clinical utility 
of MOD and VDD may be found in calculating these values for multiple refractions 
for the same patient over time. 
 
Limitations and Future Directions 
There are limitations of our study. This study focused on detection of ARFs as a 
means of further validating the latest version of the SPOTTM device for screening 
purposes. However, given the predominance of school-aged children (≥73 months 
of age) included, intervening to prevent ARFs may not be as feasible as it is in 
younger populations (<48 months of age) who are still in the critical period for 
visual development. Recent evidence suggests the primary screening focus for 
SPOTTM in school-aged children may shift from amblyopia prevention to detecting 
visual disturbances, such as refractive error.38 
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Next, despite a significant sample size, subjects were only evaluated at one time in 
space. Following fewer patients over multiple visits during a time span of years 
may provide valuable insight in helping to further interpret MOD and VDD 
threshold values for changing refractive prescriptions.  
 
The current study proportionally reflects the racial demographics of five western 
South Dakota optometry offices (Table 3). Future studies may consider sampling 
from broader populations. Efforts to yield wider applicability of findings may 
include patient sampling across South Dakota, as well as from ophthalmology and 
pediatrician office visits. Furthermore, evaluation in more geographically isolated 
areas with even fewer eye care providers per square mile than western South Dakota 
(viz. Native American reservations) may help further elucidate information on 
patient populations with the least access to eye care and a paucity of eye health 
resources. These populations may have the most to benefit from photoscreening 
technologies, given the barriers to follow-up eye care that disproportionally affect 
certain populations.42 
 
The enhancing effects of cycloplegic dilation on photoscreening are known.39  
However, approximately 42% of our subjects did not receive dilation. Future 
studies may focus on eliminating this possibly confounding variable with stricter 
control of dilation practices. Furthermore, comparing photoscreening results with 
recommendations among different health professionals (e.g., pediatricians, 
optometrists, and ophthalmologists) might lend insight into inter-specialty practice 
patterns. 
 
Cycloplegic refraction is the gold standard for assessing refractive errors. It has 
been reported the SPOTTM photoscreener overestimates the degree of astigmatism, 
regardless of the dilation/cycloplegic status of the subject being screened;5,39,43,44 
indeed, our study did find higher J0 values – corresponding with the magnitude of 
astigmatism – for the SPOTTM device compared to the ECP examination. 
Additionally, a myopic shift leading to underestimation of moderate to high 
hyperopia is a commonly accepted limitation of the SPOTTM device if cycloplegia 
is not considered.29,39,52 Thus, key stakeholders – photoscreener researchers, eye 
care-related non-profit organizations, school nurses, advanced practice providers, 
optometrists, pediatricians, and ophthalmologists – need to account for these 
considerations when designing clinical protocols to routinely and effectively 
employ photoscreeners. Specifically, 3 of the 4 FN screens in the current study may 
18
Aesculapius Journal (Health Sciences & Medicine), Vol. 2, Iss. 1 [2021], Art. 3
https://red.library.usd.edu/aesculapius/vol2/iss1/3
   
 
have been accounted for by recognizing the SPOTTM device’s underestimation of 
hyperopia.  
 
The SPOTTM photoscreening device will no doubt continue to play a role in the 
future of pediatric vision screening. It will be important to continually refine its use, 
especially in a time of increased telemedicine and a global pandemic. Ultimately, 
we hope this manuscript will contribute to increasing use and understanding of both 
the SPOTTM photoscreening device and power vector analyses, as well as helping 
to support legislation of pediatric vision screening policies in states such as South 
Dakota, without current laws in place mandating childhood eye examinations. 
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